Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn’s disease
BackgroundIn contrast to previous network meta-analysis using classical frequentist methods, we evaluated the efficacy and safety of six frequently-used biologics through a Bayesian method.MethodsWeb of Science, Scopus, CENTRAL, ClinicalTrials.gov and ICTRP were searched to collect randomized contro...
Saved in:
Main Authors: | Haohang Su, Shengwei Xiao, Zhiqing Liang, Tianrong Xun, Jinfang Zhang, Xixiao Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1475222/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease
by: Fang Wang, et al.
Published: (2025-01-01) -
New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01) -
Management of Anal Fistula with Crohn's Disease
by: Shota Takano, et al.
Published: (2025-01-01) -
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
by: Yi Li, et al.
Published: (2025-12-01) -
Features of Crohn's Disease Depending on the Age of Disease Onset
by: E. G. Ganich, et al.
Published: (2023-12-01)